January 2015 Volume 37, Issue 1, p1-242
Cervical Cancer 2015 and Beyond: A Focus on Innovative Treatments and Attention to Survivorship
Linda R. Duska
Cervical cancer is primarily a disease of less-developed countries.1 In contrast, for countries with established screening programs and access to medical care, the number of cases of cervical cancer has declined significantly over the past few decades. With the introduction of human papillomavirus (HPV) testing/typing and increasing uptake of the HPV vaccine, it is anticipated that HPV-related cervical disease (both preinvasive and invasive) will ultimately become obsolete in developed countries.